Molecular "omic" signatures in systemic sclerosis

Area of Science:

• Rheumatology
• Immunology
• Genetics

Background:

• Systemic sclerosis (SSc) is a connective tissue disease with immunologic, vascular, and matrix abnormalities.
• Clinical heterogeneity in SSc suggests variations in deregulated molecular pathway activation.
• Recent advancements have yielded substantial
• "omics" data in SSc research.

Purpose of the Study:

• To review the existing
• "omics" level research in Systemic sclerosis.
• To highlight the insights gained from each
• "omics" layer.
• To emphasize the importance of integrating multi-omics data for SSc.

Main Methods:

• Comprehensive literature review of
• "omics" studies in Systemic sclerosis.
• Analysis of genomic, transcriptomic, metagenomic, and epigenomic data.
• Synthesis of findings to understand SSc pathogenesis and heterogeneity.

Main Results:

• Each
• "omics" layer provides distinct perspectives on SSc.
• Genomic data reveals inherited predispositions.
• Transcriptomic, epigenomic, and metagenomic data offer insights into dynamic molecular changes and environmental influences.

Conclusions:

• Integrating diverse
• "omics" data (genomic, transcriptomic, epigenomic, metagenomic) is essential for a holistic understanding of SSc.
• Multi-omics integration is a critical step towards developing precision medicine approaches for SSc.
• This integrated approach is vital for identifying targeted and effective therapies for SSc patients.